Evaluating surrogate markers of clinical outcome when measured with error.

In most clinical trials, markers are measured periodically with error. In the presence of measurement error, the naive method of using the observed marker values in the Cox model to evaluate the relationship between the marker and clinical outcome can produce biased estimates and lead to incorrect conclusions when evaluating a potential surrogate. We propose a two-stage approach to account for the measurement error and reduce the bias of the estimate. In the first stage, an empirical Bayes estimate of the time-dependent covariate is computed at each event time. In the second stage, these estimates are imputed in the Cox proportional hazards model to estimate the regression parameter of interest. We demonstrate through extensive simulations that this methodology reduces the bias of the regression estimate and correctly identifies good surrogate markers more often than the naive approach. An application evaluating CD4 count as a surrogate of disease progression in an AIDS clinical trial is presented.

[1]  D. Ruppert,et al.  Measurement Error in Nonlinear Models , 1995 .

[2]  S. R. Searle Linear Models , 1971 .

[3]  M. Hughes,et al.  Regression dilution in the proportional hazards model. , 1993, Biometrics.

[4]  D. Cox Regression Models and Life-Tables , 1972 .

[5]  N P Jewell,et al.  Estimating patterns of CD4 lymphocyte decline using data from a prevalent cohort of HIV infected individuals. , 1994, Statistics in medicine.

[6]  M. Wulfsohn,et al.  Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS , 1995 .

[7]  R. Prentice Surrogate endpoints in clinical trials: definition and operational criteria. , 1989, Statistics in medicine.

[8]  Robert Schooley,et al.  CD4+ Lymphocytes Are an Incomplete Surrogate Marker for Clinical Progression in Persons with Asymptomatic HIV Infection Taking Zidovudine , 1993, Annals of Internal Medicine.

[9]  R. Prentice Covariate measurement errors and parameter estimation in a failure time regression model , 1982 .

[10]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[11]  S W Lagakos,et al.  Surrogate Markers in AIDS: Where Are We? Where Are We Going? , 1992, Annals of Internal Medicine.

[12]  Steven G. Self,et al.  Asymptotic Distribution Theory for Cox-Type Regression Models with General Relative Risk Form , 1983 .

[13]  N. Breslow Covariance analysis of censored survival data. , 1974, Biometrics.

[14]  M. Wulfsohn,et al.  The Relationship of CD4 Counts over Time to Survival in Patients with AIDS: Is CD4 a Good Surrogate Marker? , 1992 .

[15]  Richard H. Jones,et al.  Serial correlation in unequally spaced longitudinal data , 1990 .

[16]  U. Dafni,et al.  Modeling the Progression of HIV Infection , 1991 .